The significance of QT interval in drug development
Top Cited Papers
- 1 August 2002
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 54 (2) , 188-202
- https://doi.org/10.1046/j.1365-2125.2002.01627.x
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Stereoselective halofantrine disposition and effect:concentration-related QTc prolongationPublished by Wiley ,2001
- Book ReviewInternational Journal of Social Welfare, 2000
- Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 InhibitionClinical Pharmacokinetics, 2000
- Molecular genetics of the long QT syndrome: Two novel mutations of the KVLQT1 gene and phenotypic expression of the mutant gene in a large kindredHuman Mutation, 1998
- Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variabilityAmerican Heart Journal, 1996
- Female gender as a risk factor for torsades de pointes associated with cardiovascular drugsJAMA, 1993
- Clinical safety profile of sotalol in the treatment of arrhythmiasThe American Journal of Cardiology, 1993
- Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmiaThe American Journal of Cardiology, 1991
- Torsade de pointes due to quinidine: Observations in 31 patientsAmerican Heart Journal, 1984
- QT interval prolongation as predictor of sudden death in patients with myocardial infarction.Circulation, 1978